Literature DB >> 31527012

Evaluation of a quantitative enzyme-linked immunosorbent assay for feline leukemia virus p27 antigen and comparison to proviral DNA loads by real-time polymerase chain reaction.

Melissa J Beall1, Jesse Buch2, Roberta J Cahill3, Genevieve Clark4, Jancy Hanscom5, Marko Estrada6, Christian M Leutenegger7, Ramaswamy Chandrashekar8.   

Abstract

Feline leukemia virus (FeLV) is an oncogenic retrovirus of cats. While higher viral RNA and proviral DNA loads have been correlated with progressive infections and disease, a similar correlation has been suggested for p27 antigen concentrations. This analytical study compared the results of a quantitative ELISA for p27 antigen with quantitative real-time PCR results for FeLV proviral DNA in patient samples. A significant positive correlation between copies of proviral DNA and the concentration of p27 antigen was identified (r = 0.761, P < 0.0001). Samples with high proviral DNA loads, at least 1 × 106 copies/mL of whole blood, typically had p27 antigen concentrations greater than 30 ng/mL in plasma. Samples with proviral DNA loads below this level all had concentrations of p27 antigen in plasma that were less than 10 ng/mL. Given this correlation, it is hypothesized that the concentration of p27 antigen at a given point in time may help to indicate the likelihood of a progressive or regressive infection similar to what has been demonstrated for proviral DNA loads.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Cat; ELISA; FeLV; PCR; Progressive; Regressive; Retrovirus

Mesh:

Substances:

Year:  2019        PMID: 31527012     DOI: 10.1016/j.cimid.2019.101348

Source DB:  PubMed          Journal:  Comp Immunol Microbiol Infect Dis        ISSN: 0147-9571            Impact factor:   2.268


  4 in total

1.  Feline Leukemia Virus p27 Antigen Concentration and Proviral DNA Load Are Associated with Survival in Naturally Infected Cats.

Authors:  Melissa J Beall; Jesse Buch; Genevieve Clark; Marko Estrada; Andrei Rakitin; Natascha T Hamman; Monica K Frenden; Ellen P Jefferson; E Susan Amirian; Julie K Levy
Journal:  Viruses       Date:  2021-02-15       Impact factor: 5.048

2.  Treatment of acute erythroleukaemia with high-dose cytarabine in a cat with feline leukaemia virus infection.

Authors:  Da Sol Park; Jongbok Lee; Kun-Ho Song; Kyoung Won Seo
Journal:  Vet Med Sci       Date:  2021-10-02

3.  Outcome of cats referred to a specialized adoption program for feline leukemia virus-positive cats.

Authors:  Heather L Lockhart; Julie K Levy; E Susan Amirian; Natascha T Hamman; Monica K Frenden
Journal:  J Feline Med Surg       Date:  2020-04-27       Impact factor: 2.015

4.  Measuring the Humoral Immune Response in Cats Exposed to Feline Leukaemia Virus.

Authors:  Yasmin A Parr; Melissa J Beall; Julie K Levy; Michael McDonald; Natascha T Hamman; Brian J Willett; Margaret J Hosie
Journal:  Viruses       Date:  2021-03-07       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.